Skip to main content
NIH funding notice PAR-14-329

Limited Competition: Strategic Timing of Antiretroviral Treatment (START) (UM1)

Closed on November 19, 2014.

Posted
August 29, 2014
Close date
November 19, 2014
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $31,790,994 in first-year total cost, median $31,790,994.

Most frequent study sections

  1. Special Emphasis Panel[ZHL1 CSR-G (M2)]1

Most frequent institutions

  1. UNIVERSITY OF MINNESOTA1
Competing awards under PAR-14-329 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2015International Network for Strategic Initiatives in Global HIV Trials (INSIGHT): START1UM1AI120197-01NEATON, JAMES DENNISUNIVERSITY OF MINNESOTA, MN$31,790,994ZHL1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PAR-14-329: Limited Competition: Strategic Timing of Antiretroviral Treatment (START) (UM1) | ScienceDex | ConductScience